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Abstract 28 
This study examined the prevalence and correlates of use of complementary and alternative 29 
medicine (CAM) among a sample of children with autism spectrum disorder (ASD) < 7 years 30 
in 18 European countries (N=1,680).  Forty seven percent of parents reported having tried 31 
any CAM approach in the past 6 months.  Diets and supplements were used by 25% of the 32 
sample and mind-body practices by 24%; other unconventional approaches were used by 33 
25% of the families; and a minority of parents reported having tried any invasive or 34 
potentially harmful approach (2%).  Parents in Eastern Europe reported significantly higher 35 
rates of CAM use.  In the total sample, children with lower verbal ability and children using 36 
prescribed medications were more likely to be receiving diets or supplements.  Concurrent 37 
use of high levels of conventional psychosocial intervention was significantly associated with 38 
use of mind-body practices.  Higher parental educational level also increased the likelihood 39 
of both use of diets and supplements and use of mind-body practices.  Conclusion: The high 40 
prevalence of CAM use among a sample of young children with ASD is an indication that 41 
parents need to be supported in the choice of treatments early on in the assessment process, 42 
particularly in some parts of Europe. 43 
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Authors Summary 60 
What is Known  61 
 Use of complementary and alternative medicine (CAM) in children with autism 62 
spectrum disorder is common.  63 
 In non-EU samples, parents with higher educational level and parents of low 64 
functioning children are more likely to use CAM with their children 65 
What is New 66 
 This study provides the first data on prevalence and correlates of use of CAM 67 
approaches in a large sample of young children with autism in Europe (N=1680). 68 
 Rates of CAM use were particularly high in Eastern Europe and correlates of use 69 
varied by type of CAM across Europe. 70 
 71 
 72 
 73 
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 24 
Introduction 25 
Autism spectrum disorder (ASD) is a behaviourally defined disorder characterized by 26 
impairments in social communication abilities and the presence of restricted and repetitive 27 
behaviours and atypical sensory responses [3].  Despite the evidence that behavioural and 28 
social communication interventions can ameliorate symptoms and improve outcomes [29] it 29 
is not a condition for which a ‘cure’ is currently available.  The uncertainty concerning the 30 
developmental outcomes, the limitations to existing treatments, and the lack of a simple cure 31 
have been indicated as possible reasons for the high prevalence of use of therapies based 32 
outside the domain of conventional medical and psychological practice by families of 33 
children with autism [21].  Such therapies, generally defined as complementary and 34 
alternative medicine (CAM), comprise a myriad of “interventions” that range from unproven 35 
and untested treatments to approaches that have been found to be harmful.  The National 36 
Center for Complementary and Alternative Medicine (NCCAM) distinguishes the following 37 
broad areas of CAM: ‘natural products’ (often sold as dietary supplements), ‘mind and body 38 
practices’ (such as massage or sensory integration therapy) and a residual category of other 39 
complementary health approaches that do not fit neatly in the previous ones, such as 40 
homeopathy (http://nccam.nih.gov/).  Research on CAM use broadly refers back to this 41 
classification, but additional meaningful categories of CAM such as “invasive or potentially 42 
unsafe approaches" [1] and other unconventional approaches that are not strictly classifiable 43 
as CAM (such as pet therapy) are also often included in such surveys.  This, and the fact that 44 
the NCCAM classification has changed over time, have led to some inconsistency across 45 
studies.   46 
3 
 
The efficacy of CAM treatment is controversial, but for most of these approaches 47 
there simply is not enough evidence to evaluate them [23].  For example, while gluten- and 48 
casein-free diets are widely used and reported to be efficacious by parents [40], to date only 49 
two RCTs have tested their efficacy, yielding mixed results that prevent any recommendation 50 
of these exclusion diets as standard treatments [19,8].  Omega-3 fatty acids are increasingly 51 
used in ASD despite lack of understanding on which might be the optimal dosage and 52 
insufficient evidence of efficacy [18].  Moreover, while CAM is often used in combination 53 
with medication, little is known about potential aversive effects of the interaction between 54 
drugs and supplements, which requires careful monitoring [20].  There is some positive 55 
evidence for some CAM approaches, such as horse-riding [16] and massage [34].  A 56 
Cochrane review of auditory integration training, a costly and theoretically ill-specified 57 
treatment, did not find sufficient evidence to support its use [35].  58 
In US based samples, there is some evidence that CAM use in children or young 59 
people with ASD is associated with greater functional difficulty [15,32,38], but this has not 60 
always been replicated [1].  A higher parental educational level and high levels of use of 61 
conventional therapy (>20 hours) have also been found to be associated with CAM use in 62 
children with ASD [1].  Cultural and systemic factors (such as families’ own recognition and 63 
beliefs around aetiology and course of symptoms as well as the actual availability of 64 
conventional therapy) might also play a role in the decision to use CAM [25].  Professionals’ 65 
opinions vary widely on the topic [31] and might be another source of influence on family 66 
choice.  These aspects are likely to differ in different parts of the world [4], however with the 67 
exception of a non-systematic review based on professionals’ opinions [41] no studies to date 68 
report on the use of CAM in Europe. Moreover, different factors might play a different role in 69 
use of specific types of CAM, but this is only beginning to be addressed [32].  The present 70 
study aimed at describing the prevalence of use of CAM in Europe, as well as identifying the 71 
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correlates of use of the two main classes of CAM: diets and supplements and mind-body 72 
practices.   73 
Methods 74 
Ethical approval was given by the Research Ethics Committee of the Faculty of 75 
Children and Learning, Institute of Education, London, UK. Parents provided informed 76 
consent before completing the survey (IOE/ FPS 385). 77 
Survey 78 
The present study focuses on a set of questions on use of CAM that was part of a 79 
wider-scope survey on use of interventions in Europe [33, in press].  The survey was open for 80 
completion for 45 days. A total of 1,680 families with a child with ASD aged 7 or younger in 81 
18 countries completed the online survey: Belgium, Czech Republic, Denmark, Finland, 82 
France, Germany, Hungary, Iceland, Ireland, Italy, Netherlands, Norway, Poland, Portugal, 83 
Romania, Spain, The Former Yugoslav Republic of Macedonia and the United Kingdom.  84 
Participants were recruited via national parents’ associations who advertised the link on their 85 
websites, with the exception of parents in The Former Yugoslav Republic of Macedonia who 86 
were recruited through the Paediatric Clinic of Skopje in absence of a national parents’ 87 
association and completed a paper version of the survey.  Before launching the survey, the 88 
questionnaire was piloted with parents from the UK (N=8) and Italy (N=2); as a result of the 89 
pilot, the possibility to select a generic intervention if the nature of the approach was not 90 
known to the parent was further highlighted in the initial instructions. Participant 91 
characteristics are summarised in Table 1.   92 
Parent characteristics: General background information on respondents was 93 
gathered: relationship to child (mother/father/other) and educational level (below high school 94 
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diploma, high school diploma, bachelor/degree, postgraduate).  The educational level was 95 
collapsed for analysis into the following two categories: low educational level (up to high 96 
school diploma, 37%) and high educational level (degree and postgraduate, 63%).  To 97 
comply with the relevant legislation on cross-national sharing of sensitive personal data in 98 
some of the participating countries, parents were asked to report on the country of residency 99 
but data on nationality and ethnicity were not collected. 100 
Child characteristics: Information on the age of the child at survey completion was 101 
collected and dichotomised to reflect the age at which typically children start school in 102 
Europe (below age 5, 52% and 5 years and above, 48%). Child verbal ability was rated by 103 
parents selecting one of five options (does not talk; uses single words; uses two- or three-104 
word phrases; uses sentences with four or more words; uses complex sentences).  The options 105 
were collapsed into two categories for the purposes of analysis: low verbal ability (non-verbal 106 
or single words speech, 37%) and use of at least phrase speech (63%).   107 
Use of conventional therapies and prescription medication: Parents were asked to 108 
report on current use of conventional behavioural, developmental and psychosocial 109 
intervention (such as applied behavioural analysis, occupational therapy, speech and language 110 
therapy…) and medication.  A total of 1,529 parents (91%) reported using at least one 111 
conventional intervention.  The number of conventional interventions used ranged from 1 to 7 112 
(M=2.39, SD=1.43; IQR: 1-3); more detailed results are reported in [33, in press]. For the 113 
purposes of this analysis, we classified the sample for level of use of conventional treatments.  114 
Three levels of use were defined based on the distribution of number of interventions used: 115 
no use (0 therapies used; 9%), medium level of use (use of 1-3 therapies; 70.5%) and high 116 
level of use (use of 4 or more therapies; 20.5%).  Parents reported using at least one 117 
medication in 19.7% of cases in the total sample. Use of medication was dichotomised for 118 
this analysis into a “use of any medication” binary variable.  119 
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CAM: A list of CAM approaches was drawn from the literature.  Parents were asked 120 
to endorse all the approaches that they had used with their child in the previous 6 months.  121 
The CAM approaches, listed alphabetically in the form, were successively classified into four 122 
categories for the purpose of statistical analysis: the three categories proposed by the 123 
NCCAM (diets and supplements; mind and body practices; other unconventional approaches) 124 
and a fourth category of “invasive, disproven or potentially unsafe CAM” (including 125 
chelation, hyperbaric oxygen therapy and packing) which was added [following 1].   126 
 127 
Data analysis 128 
Descriptive statistics were used to report on use of each CAM approach, grouped in 129 
four over-arching categories.  Prevalence of use of these categories was examined in the total 130 
sample and by European regions [37]: Western Europe (Belgium, France, Germany and 131 
Netherlands), Northern Europe (Denmark, Finland, Iceland, Ireland, Norway, United 132 
Kingdom), Eastern Europe (Czech Republic, Hungary, Poland, Romania) and Southern 133 
Europe (Italy, Macedonia, Portugal, Spain).   134 
To investigate the association of child and parental characteristics with use of CAM, 135 
we conducted logistic regressions on the total sample for two primary outcomes: use of any 136 
diets or supplements and use of any body-mind practices.  These categories were selected for 137 
the analysis on the basis of the following criteria: conceptual relevance, homogeneity of 138 
approaches included and frequency of use.  In each model, the predictors were: child’s 139 
gender, verbal ability and age, parental educational level, use of any prescription medication, 140 
use of conventional therapies categorised into three dummy variables (no use of therapy, 141 
medium level of use, and high level of use; the first category was used as the reference). 142 
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Results 143 
---- Table 1 about here ----- 144 
Frequency of CAM 145 
Frequency of use of individual CAM approaches is reported in Table 2.  A total of 146 
789 respondents (47%) reported using at least one type of CAM.  The rate of use of any 147 
CAM was significantly higher in Eastern (66%) than in Western (41%, p<.001), Northern 148 
(46%, p<.001) and Southern (40%, p<.001) Europe.  The prevalence of use in Northern 149 
Europe was also significantly higher than in Southern Europe (p=.038).  In the total sample, 150 
the most commonly used CAM approaches were diets and supplements (24.4% reported 151 
using any); use of vitamins was reported by 259 parents (15.4%) and gluten or casein free 152 
diets were reported by 227 (13.5%).  The proportion of parents reporting using diets and 153 
supplements was significantly higher in Eastern Europe (38%) than in Western (17%, 154 
p<.001), Northern (28%, p=.003) and Southern Europe (20%, p<.001). Reported use in 155 
Northern Europe was also significantly higher than use in Western (p<.001) and Southern 156 
Europe (p=.007).  Mind and body practices were reported by 395 respondents in the total 157 
sample (23.5%); among these, sensory integration therapy (13.6%) and massage (7.1%) were 158 
the most commonly used treatments.  Parents in Eastern Europe also reported the highest rate 159 
of use of any mind-body practices (34%); this proportion was significantly higher than rates 160 
in Western (20%, p<.001), Northern (28%, p=.043) and Southern Europe (16%, p<.001).  161 
Reported use of mind-body practices in Northern Europe was also significantly higher than in 162 
Southern (p<.001) and Western Europe (<.006).  A number of other unconventional 163 
approaches not included in the previously mentioned classes of CAM were reported in 24.5% 164 
of the total sample (n=514): among these, pet therapy (n= 233, 13.9%) and homeopathy 165 
(n=161, 9.6%) were the most widely used.   The proportion of parents reporting using such 166 
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approaches was significantly higher in Eastern Europe (43%) than in Western (24%, p<.001), 167 
Northern (12%, p<.001) and Southern Europe (19%, p<.001). Reported use in Western and 168 
Southern Europe was also significantly higher than in Northern Europe (p<.001 and p=.006).  169 
A small minority of parents (n=40, 2.4%) reported using any invasive, disproven or 170 
potentially unsafe CAM (chelation, hyperbaric chamber and packing).  Rate of use of such 171 
approaches was significantly higher in Eastern Europe (5%) than in Western (0.8%, p<.001), 172 
Northern (1.5%, p=.006) and Southern Europe (2.5%, p=.037).  The rate in Southern Europe 173 
was also significantly higher than the rate in Western Europe (p=.034).  The total number of 174 
different CAM approaches used for those parents who used any CAM approaches ranged 175 
from 1 to 12 with a mean of 2.15 (SD=1.55, IQR: 1-3) in the total sample.  A significant 176 
effect of European region was found on number of CAM approaches used, F (3, 785) = 9.72, 177 
p<.001, ω=.18.  Post hoc comparisons indicated that the mean number of approaches used 178 
with children living in Eastern Europe (M = 2.60, SD = 1.87, IQR: 1-3) was significantly 179 
higher than the mean number of approaches used with children living in Western Europe (M 180 
= 1.92, SD = 1.40, IQR: 1-2; p<.001), Northern Europe (M = 2.06, SD = 1.22, IQR: 1-3; 181 
p=.004) and Southern Europe (M = 1.93, SD = 1.42, IQR: 1-2; p<.001).   182 
----- Table 2 about here ----- 183 
Predictors of CAM use 184 
Logistic regression models were performed on the total sample with use of any 185 
diets/supplements and use of any mind-body practice as outcome variables.  Table 3 reports 186 
the odds ratios and 95% CIs for the predictors of each logistic regression model.  For all 187 
models, the χ² statistics were significant (all p < .001) and the Hosmer & Lemeshow’s 188 
goodness-of-fit tests [17] were not significant (hence indicating well-fitting models).  The 189 
Nagelskerke’s R2 [27] were low (range .03-.08), which is an indication that several other 190 
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relevant variables had not been included in the model.  For each predictor, the effects 191 
reported below are intended to be over and above the effect of all other variables included in 192 
the model.  193 
----- Table 3 ----- 194 
Use of any diets/supplements 195 
Use of any diets or supplements was significantly associated with low verbal ability in 196 
the children and higher parental educational level.  Use of prescription medication increased 197 
the likelihood of using diets or supplements by 62%.  Child’s gender and age and use of 198 
conventional therapy were not predictors of using diets or supplements.   199 
Use of any mind-body practices 200 
Mind and body practices were less likely to being used with boys than with girls.  A 201 
higher parental educational level and high levels of use of conventional psychosocial 202 
interventions were associated with concurrent use of mind-and-body practices.  Child’s age 203 
and verbal ability, use of medication and medium levels of use of conventional treatments 204 
were not associated with use of this category of CAM.  205 
Discussion 206 
This study is the first to report on use of CAM in young children with autism in 207 
Europe.  We found that overall 47% of parents reported using at least one type of CAM or 208 
other unconventional treatment in the previous 6 months.  Rates of use were homogeneous 209 
across Europe with the exception of significantly higher rates in Eastern Europe (66%).  210 
Prevalence data from US samples obtained from reviews of patients charts vary from 30-50% 211 
[21,32,1] to 70-90% [14,15].  In the total sample, parents reported using diets or supplements 212 
in 24% of cases.  Previous reports of use of diets ranged 27%-42% [11,13,15], but 213 
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comparisons are made difficult by the different level of detail across studies.  A similar 214 
proportion of parents in our total sample reported using mind-body practices (24%).  Rates 215 
from previous studies ranged 20-30% [15,14], but comparison should be made with caution 216 
as different definitions were used or CAM approaches were considered individually rather 217 
than as a class.   218 
We also enquired about some invasive or potentially harmful treatments: chelation, 219 
hyperbaric chamber and packing.  Chelation is medical procedure involving administering 220 
various chemical substances for the purpose of binding and then withdrawing specific metals 221 
from the person's body; its potential serious side effects (including death) and the lack of 222 
sound scientific rationale argue against its therapeutic use [6].  Hyperbaric oxygen therapy 223 
involves breathing oxygen in a pressurized chamber for the purpose of increasing the amount 224 
of oxygen in the blood; it is both ineffective [12] and unsafe (potential side effects include 225 
paralysis and air embolism).  Packing involves wrapping the individual in towels previously 226 
wet in cold water to supposedly reinforce the individuals’ consciousness of their bodily 227 
limits; this practice, which appears to be a clear violation of human rights, has not been 228 
evaluated systematically [7].  In our sample, 40 parents (2%) reported using any of these 229 
treatments with their children. 230 
Among the other unconventional treatments included in the survey, it is relevant to 231 
note the high prevalence of reported use of pet therapy (14%).  Pet-therapy is a generic term 232 
that encompasses both the use of “assistance” pets (i.e., placement of a pet in the family) and 233 
the use of “therapy” pets by a therapist at home or in other settings; it is not possible to know 234 
whether in our sample parents were endorsing the former or the latter.  Higher figures (24%) 235 
have been reported before [5].  236 
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There were significant regional differences in the rates of use of the four over-arching 237 
categories of CAM, with consistently higher rates in Eastern Europe than in the rest of 238 
Europe.   This might be due to lack of access to evidence-based information in those 239 
countries, possibly as a residual consequence of the historical divide on health policies in 240 
Europe [24] or to cultural differences in attitudes of professionals and community members 241 
that are only beginning to be explored [41].  242 
We were interested in identifying correlates of use of CAM in Europe. As CAM is 243 
comprised of a plethora of different types of “treatments”, we investigated correlates of use 244 
of the two main classes of approaches, selected for their conceptual relevance and relative 245 
homogeneity: diets and supplements and mind-body practices.  No gender differences were 246 
found for use of diets and supplements. There was a tendency for more mind-body practices 247 
to be used with girls than with boys, but this finding should be interpreted with caution as the 248 
females in the sample were only a minority (n=291, 18%).  In our sample, non-verbal 249 
children and children with single-words speech were more likely to being treated with diets 250 
(30% increase in the probability of use), suggesting that parents of lower functioning children 251 
may tend to look to a range of interventions to respond to more severe difficulties. 252 
Additionally, over and above the effect of verbal ability, children using prescription 253 
medication were also more likely to be treated with diets than children not using medication 254 
(62% increase).  Interestingly though, neither of these associations was found for use of 255 
mind-body practices.  This suggests that previous evidence of higher use of CAM in low 256 
functioning children [32,14] might be specific to some CAM types.  The association of use of 257 
medication with use of diets but not mind-body practice might be due to the use of 258 
supplements or alterations in the diet as an attempt to counter-balance potential side effects of 259 
medications or to “boost” their efficacy [15].  Alternatively, the association could reflect 260 
parental attitudes or beliefs (e.g., a generic belief in chemical/biological mechanisms) or the 261 
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willingness of the child to orally intake pills or tablets.  Increased diet use in children 262 
concurrently taking medications may also reflect an attempt to counteract the weight-gain 263 
associated with many psychotropic medications, although we did not ask parents to report 264 
why their child was on a diet, which should be done in future studies.  In addition, we do not 265 
have information on whether diets or supplements were medically prescribed as a treatment 266 
for specific conditions (such as iron deficiency).    267 
Parents with a high educational level have been consistently reported in previous 268 
studies to be more likely to use CAM than parents with a lower educational level [14,1] and 269 
in our study more educated parents were more likely to choose diets or supplements for their 270 
child as well as using mind-and body practices.  Notably, the increase in the likelihood was 271 
higher for the mind-body practices (64%) than diets and supplements (35%). Mind-and-body 272 
practices are practitioner-delivered and their cost is on average almost double the cost of self-273 
care therapies such as supplements [28], and this might explain why in our sample mind-and-274 
body practices were significantly less used by parents with a lower SES (indexed by their 275 
educational level).  276 
When the correlation of CAM use and use of conventional treatments has been 277 
explored, it appears that availability and use of conventional treatments does not lessen use of 278 
CAM.  Indeed, CAM use has been found to be associated with receiving 20 or more hours 279 
per week of conventional treatment [1].  Here, we explored the association between use of 280 
conventional treatments and use of two specific classes of CAM.  There was no association 281 
between use of conventional treatment and use of diets: the use of such approaches might in 282 
fact be more related to the use of medications, as suggested above.  We found instead a large 283 
dose-response effect of use of conventional treatments on use of mind-body practices with a 284 
four-fold increase in the likelihood of concurrent CAM use for parents reporting already 285 
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using more than four conventional treatments for their child, but not for medium levels of 286 
treatment (up to three interventions).   287 
This finding suggests that use of mind-body practices is most strongly related with a 288 
tendency to try a wide number of approaches; this might indicate that some parents, over and 289 
above the effect of their child’s level of functioning (measured as verbal ability) and of their 290 
own educational level (which can be constructed as a proxy of their SES), tend to look for as 291 
many therapies as possible, whether these be conventional treatments or CAM approaches.  292 
Use of diets appeared to be most strongly associated with lower functioning of the child and 293 
concurrent use of prescription medication.   294 
There is concern that desperate parents may resort to unsafe or disproven CAM 295 
approaches and public agencies have been actively campaigning against them [10], but such 296 
approaches were not in wide use in our sample. However, animal-assisted therapy, whose 297 
efficacy is not yet established, is attracting increasing interest [30] and a considerable number 298 
of parents reported using such approaches in our sample.  These findings have implications 299 
for clinicians and professionals involved in the care of children with ASD, in that they should 300 
engage parents in frank discussions about CAM approaches, the available evidence and any 301 
potential for adverse effects.   302 
Strengths and limitations  303 
There are a number of strengths to the present study, including the large sample size 304 
and the wide scope of the survey, which enquired about the use of a range of both CAM 305 
approaches and conventional treatments for young children with autism in Europe.  306 
Moreover, while previous research has looked at predictive factors for use of CAM 307 
considering child and parent characteristics as individual factors or only adjusting for parental 308 
education level, in our study we used multiple logistic regression to estimate the contribution 309 
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of each predictor having taken into account the influence of the other factors. These findings 310 
can help to identify families potentially more likely to adopt CAM approaches, and this 311 
information may be beneficial both to primary care providers in their role as clinical advisors, 312 
and to researchers, for example when designing trials of CAM approaches.  313 
Nevertheless, the findings should be seen in the context of some limitations.  Firstly, 314 
we employed a recruitment method (online survey advertised via parents’ associations) that 315 
might have been prone to selection bias since parents involved in associations are more likely 316 
to have a relatively high income and educational level [26] and internet access is still a 317 
function of socio-demographic characteristics in Europe [39].  Our sample had in fact a 318 
higher than average education level [9].  However, while the recruitment strategy used 319 
necessarily prevents any claims of generalizability of our results to the European population, 320 
it has enabled us to reach a large number of families across Europe.  Moreover, it has been 321 
argued that, given the controversy around use of CAM, an anonymous online survey might 322 
actually better protect against the potential risks of selection and reporting bias [36], than 323 
when parents are directly asked by clinicians (as happened in most other studies on the topic).  324 
Furthermore, we found that reported levels of CAM use in the present study were similar to 325 
previous studies in non-EU samples. 326 
The factors examined in the present study are only some of the many that might affect 327 
the decision-making process underlying the choice of using CAM alongside (or alternative 328 
to) conventional healthcare, which is still largely unexplained.  For example, there is 329 
preliminary evidence from a small sample of French parents (N=89) that personality 330 
characteristics such as personal control and attribution of cause of autism affect the decision 331 
to use CAM or not [2].  Parents’ own use of CAM is likely to be a relevant factor but has 332 
never been examined in the association with use of CAM in children.  Further research on the 333 
topic should include these and other factors, such as beliefs on ASD aetiology, to better 334 
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understand the phenomenon of use of CAM for children with autism. Finally, reliance on 335 
parent report in absence of direct assessments places a limitation on these findings in relation 336 
to severity of child symptoms and behavioural characteristics. 337 
Conclusions 338 
This was the first study to report on factors associated with use of CAM in a large 339 
sample of young children with autism in Europe. While little is known on the efficacy (and 340 
conversely, on the potential harm) of CAM approaches, a vast amount of uncontrolled 341 
information is available on-line, putting parents at risk of embarking in sometimes costly and 342 
often non-efficacious treatments.  Rates of CAM use, including use of disproven or unsafe 343 
approaches, were particularly high in Eastern Europe.  The present study contributed to the 344 
understanding of the factors associated to use of CAM and provided some evidence that 345 
families that tend to use a wide range of conventional treatments might also be more likely to 346 
be trying some CAM approaches.  The reasons behind this are not fully understood, and may 347 
reflect factors that were not captured by the present study.  Nonetheless these findings, taken 348 
together with the evidence of socio-economic barriers in access to treatment for autism 349 
[22,33, in press], provide some insight into the lengths to which families may go in pursuit of 350 
ways to help their child progress.  The findings highlight the need to further advance research 351 
funding and policy development for evidence-based early interventions for children with 352 
ASD across Europe.  353 
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  Tables 1 
Table 1 Participants 2 
 
  
Europe 
(N=1,680) 
Gender  
 Male n (%) 1,389 (82.7%) 
Age   
 Months M (SD) 58.18 (14.04) 
 ≤ 5years n (%) 880 (52.4 %) 
 > 5 years n (%) 800 (47.6 %) 
Verbal ability  
 non-verbal /single words n (%) 620 (36.9%) 
 at least phrase speech n (%) 1,060 (63.1%) 
Respondent educational level  
 up to high school diploma n (%) 615 (36.6%) 
 graduate and postgraduate n (%) 1,065 (63.4%) 
Use of medication  
 at least one n (%) 331 (19.7%) 
Use of conventional therapies  
 n. of therapies  M (SD) 2.39 (1.43) 
 no use of therapies n (%) 151 (9%) 
 using 1 to 3 therapies n (%) 1,184 (70.5%) 
 using 4+ therapies n (%) 345 (20.5%) 
2 
 
Table 2 Use of CAM in Europe 3 
CAM and Unconventional 
Approaches  
 
Europe 
(N=1,680) 
 
Western  
Europe 
(n=473) 
Northern 
Europe 
(n=341) 
Eastern 
Europe 
(n=354) 
Southern 
Europe 
(n=512) 
 N (%) N (%) N (%) N (%) N (%) 
Diets and supplements      
 vitamins 259 (15.4%) 33 (7%) 61 (17.9%) 101 (28.5%) 64 (12.5%) 
 gluten/casein free diet 227 (13.5%) 43 (9.1%) 40 (11.7%) 71 (20.1%) 73 (14.3%) 
 yeast free diet 30 (1.8%) 7 (1.5%) 7 (2.1%) 9 (2.5%) 7 (1.4%) 
 other diet 77 (4.6%) 25 (5.3%) 28 (8.2%) 18 (5.1%) 6 (1.2%) 
Any diet or supplements 410 (24.4%) 80 (16%) c 94 (27.6%) b 133 (37.6%) a 103 (20.1%) c 
       
Mind and body practices      
 acupressure 6 (0.4%) 1 (0.2%) 2 (0.6%) 3 (0.8%) 0 (0%) 
 acupunture 6 (0.4%) 1 (0.2%)  0 (0%) 1 (0.3%) 4 (0.8%) 
 
auditory integration 
training 40 (2.4%) 4 (0.8%)  0 (0%) 19 (5.4%) 10 (2%) 
 biofeedback 15 (0.9%)  0 (0%)  0 (0%) 10 (2.8%) 4 (0.8%) 
 craniosacral therapy 40 (2.4%) 8 (1.7%) 13 (3.8%) 8 (2.3%) 11 (2.1%) 
 deep pressure therapy 48 (2.9%) 9 (1.9%) 31 (9.1%) 4 (1.1%) 4 (0.8%) 
 massage 119 (7.1%) 33 (7%) 33 (9.7%) 40 (11.3%) 13 (2.5%) 
 osteopathy 45 (2.7%) 34 (7.2%) 2 (0.6%) 2 (0.6%) 7 (1.4%) 
 sensory integration therapy 228 (13.6%) 35 (7.4%) 46 (13.5%) 93 (26.3%) 54 (10.5%) 
Any mind and body 
practice 395 (23.5%) 95 (20.1%) c 95 (27.9%) b 121 (34.2%) a 84 (16.4%) c 
      
Invasive, disproven, or 
potentially unsafe CAM      
 chelation 25 (1.5%) 3 (0.6%) 2 (0.6%) 13 (3.7%) 7 (1.4%) 
 hyperbaric oxygen therapy 13 (0.8%) 1 (0.2%)  0 (0%) 4 (1.1%) 8 (1.6%) 
 packing 4 (0.2%) 0 (0%) 3 (0.9%) 1 (0.3%) 0 (0%) 
Any invasive, disproven or 
unsafe 40 (2.4%) 4 (0.8%) c 5 (1.5%) b, c 18 (5.1%) a 13 (2.5%) b 
       
Other unconventional 
approaches      
 aromatherapy 26 (1.5%) 10 (2.1%) 6 (1.8%) 9 (2.5%) 1 (0.2%) 
 
Doman Delacato 
patterning 15 (0.9%) 1 (0.2%) 1 (0.3%) 7 (2%) 6 (1.2%) 
 facilitated communication 47 (2.8%) 21 (4.4%) 1 (0.3%) 15 (4.2%) 10 (2%) 
 holding therapy 27 (1.6%) 4 (0.8%) 5 (1.5%) 15 (4.2%) 3 (0.6%) 
 homeopathy 161 (9.6%) 61 (12.9%) 8 (2.3%) 56 (15.8%) 36 (7%) 
 oxytocin 5 (0.3%) 2 (0.4%) 1 (0.3%)  (%) 2 (0.4%) 
 pet therapy 233 (13.9%) 40 (8.5%) 25 (7.3%) 106 (29.9%) 62 (12.1%) 
Any other unconventional 
approach 411 (24.5) 114 (24.1%) b 41 (12%) c 154 (43.5%) a 102 (19.9%) b 
      
Any CAM /unconventional 
approaches 789 (47%) 196 (41.4%) b, c 157 (46%) b 233 (65.8%) a 203 (39.6%) c 
Note: Frequencies in a row without a common superscript letter are significantly different at the .01 level 
according to χ² tests (p ranged from <.001-.006). 
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 4 
Table 3 Predictors of CAM use in Europe 5 
 6 
  Any diets/supplements  Any mind/body practice 
   OR (p)  95% CI   OR (p)  95% CI 
      
 Child’s age (>5 years) 1.03 (.818) .81-1.30  1.17 (.207) .92-1.49 
 Child’s gender (male) .97 (.812) .72-1.30  .68 (.010) .51-.91 
 Child’s verbal ability (non-verbal) 1.30 (.034) 1.02-1.65  1.18 (.201) .92-1.51 
 Parental educational level (high) 1.35 (.013) 1.07-1.72  1.64 (<.001) 1.27-2.11 
 Use of prescription medication 1.62 (<.001) 1.24-2.12  1.26 (.110) .95-1.67 
 Conventional therapy: use of 1-3 therapies 1.13 (.585) .74-1.71  1.60 (.069) .96-2.65 
 Conventional therapy: use of 4+ therapies 1.41 (.151) .88-2.24  4.36 (<.001) 2.56-7.42 
       
 . 
χ²(7)= 28.055, p<.001; 
H-L χ² ns; R²= .03 
 χ²(7)= 95.548, p<.001; 
H-L χ² ns; R²= .08 
 7 
